Wednesday, November 30, 2005

Bloodwork in Cary - no chemo (view this post) (print this post) :: No comments

Day 15 of clinical trial cycle #2 - Abraxane cancelled due to too-low platelet count. Dan will get his blood rechecked Friday.

Monday, November 28, 2005

Blood recheck #11 (view this post) (print this post) :: No comments

Dan’s bloodwork rechecked - low but stable

Saturday, November 26, 2005

Mar & Ed’s wedding (view this post) (print this post) :: No comments

We didn’t make it to PA for Marilyn and Ed’s wedding … Dan wasn’t up to the trip.

Thursday, November 24, 2005

Photo of Dan - Thanksgiving (view this post) (print this post) :: No comments

Here’s Dan with his family’s cat Audrey, on Thanksgiving Day before dinner at their house.

Wednesday, November 23, 2005

2nd Abraxane dose (view this post) (print this post) :: No comments

Clinical trial 2, cycle 2 - Abraxane 3/4 dose

Monday, November 21, 2005

Blood recheck #10 (view this post) (print this post) :: No comments

Bloodwork good, weight stable - working on steroid prescription coverage

Wednesday, November 16, 2005

Start cycle 2 (view this post) (print this post) :: No comments

Day 1 of Cycle 2 of the chemo clinical trial - 3/4 dose of Abraxane, full dose of carboplatin, Darbepoetin shot to boost his red blood cells.

Monday, November 14, 2005

Re-evaluation before cycle 2 (view this post) (print this post) :: 3 comments

Re-evaluation of keeping Dan in the Abraxane trial for a 2nd cycle: it’s a go. Dan got an anabolic steroid prescription to help him with his appetite and weight loss, but we’ll have to challenge our prescription insurer to try to get it paid-for.

Saturday, November 12, 2005

Liz & LAF event (view this post) (print this post) :: No comments

Memento from Liz volunteering at an LAF event in Portland

Friday, November 11, 2005

Cary eval pre cycle 2 (view this post) (print this post) :: No comments

Dan’s blood counts are much better as of the Friday before we decide whether Dan should proceed with the 2nd cycle of the Abraxane trial.